News Breaks |
|
|
| October 3, 2012 |
| 07:21 EDT |  | WPI | Watson Pharmaceuticals price target raised to $98 from $88 at RBC Capital
RBC Capital believes that Watson has "numerous" potential catalysts that aren't reflect in analysts' estimates. The firm thinks that the company can beat 2013 EPS estimates by a significant amount, and it maintains an Outperform rating on the stock. |
|
|
News For WPI From The Last 14 Days Check below for free stories on WPI the last two weeks. |
|
|
| There are no results for WPI |
|
|
|
|
